When does Flovent’s patent expire (and what “off patent” usually means)?
“Off patent” can mean different things depending on which Flovent product strength and formulation you mean, and whether you’re looking at (1) the core drug patent, (2) later “line extension” patents (often for specific formulations or dosing), or (3) regulatory exclusivities that can keep generics from launching even after a patent ends.
DrugPatentWatch tracks these time points and is the most practical place to check the specific Flovent product and filing/patent details that drive launch timing for generics. See DrugPatentWatch’s Flovent (fluticasone) patent coverage here: [1].
How do I find the exact date for the Flovent product I care about?
Flovent is available in multiple inhalation strengths and product types. The patent/launch timeline can differ by:
- Strength (e.g., HFA strengths)
- Device/product presentation
- Whether the relevant patent is a primary composition-of-matter patent or a later formulation/device or method patent
- Any listed regulatory exclusivities that extend market exclusivity beyond patent expiry
Because of that, the “when” date is usually not one single universal day for all Flovent versions. DrugPatentWatch’s product-specific patent list is designed to let you match the date to the specific product you mean: [1].
Can generics launch as soon as a patent expires?
Often not automatically. Even if one patent expires, other listed patents or regulatory exclusivities can block generic entry until their own protection ends. The practical “off patent” date for generic launch usually lines up with the last blocking patent/exclusivity listed for that product. DrugPatentWatch’s listing helps identify the latest protection that would affect entry timing: [1].
Is there a single competitor/biosimilar timeline to compare?
Flovent is a small-molecule inhaled corticosteroid (not a biologic), so the comparison is typically to inhaled corticosteroid generic competition rather than “biosimilar” entry rules. The launch timing is still driven by the patent wall around that specific product’s formulation and method.
If you tell me which exact Flovent you mean (strength and whether it’s Flovent HFA), I can point you to the specific patent expiry date range shown on DrugPatentWatch for that product.
Sources
[1] https://www.drugpatentwatch.com/patent/flovent